NASDAQ · ESLA
Estrella Immunopharma, Inc.
$0.73-$0.09 (-11.32%)
Estrella Immunopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.87% below the high.
Loading market information…
NASDAQ · EFHT · USD
Stock price, earnings
Quote as of Dec 12, 2023, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
EF Hutton Acquisition Corporation I Common Stock’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow EF Hutton Acquisition Corporation I Common Stock’s reporting calendar.
THE COMPANY BEHIND THE TICKER
As of December 12, 2023, EF Hutton Acquisition Corporation I concluded a reverse merger with Humble Imports, Inc. Prior to this event, EF Hutton Acquisition Corporation I, which was founded in 2021 and has its headquarters in Hingham, Massachusetts, operated as a special purpose acquisition company (SPAC). It did not conduct any substantial business operations independently. Its initial aim was to seek out and finalize a business combination – such as an acquisition, merger, or stock exchange – with one or more companies in the consumer and retail industry.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.73-$0.09 (-11.32%)
Estrella Immunopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.87% below the high.
$7.35+$0.89 (+13.78%)
American Acquisition Opportunity Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.58% below the high.
$6.11-$0.97 (-13.71%)
Goldenbridge Acquisition Limited’s quoted price sits in the lower half of its reported 52-week range, 46.87% below the high.
$6.56-$0.64 (-8.89%)
Global Star Acquisition, Inc. Class A Common Stock’s quoted price sits in the lower half of its reported 52-week range, 68.6% below the high.
$3.66-$7.03 (-65.76%)
Bukit Jalil Global Acquisition 1 Ltd’s quoted price sits in the lower half of its reported 52-week range, 69.95% below the high.
$2.20$0.00 (0.0%)
TMT Acquisition Corp: Financial Services · Shell Companies.
$3.82-$6.58 (-63.27%)
Alset Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 74.6% below the high.
$5.18+$0.47 (+9.98%)
Mobiv Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 55.91% below the high.
